CONDITIONAL
Implant and Radiology Intelligence
CONDITIONAL — JUNE AND JULY 2026 Implant and Radiology Intelligence. From WilhelmAI.
Welcome to the first issue of Conditional. My name is Tony Oropeza and I’m a multi-modality tech in the Bay Area, plus founder of WilhelmAI. Every month we will feature the news that actually reaches the imaging rooms. Recalls, clearances, contrast, and the practice and policy stories worth your time. Four sections, 10+ recent stories, five minutes.
FROM THE SCAN ROOM
Reading this issue back, there’s a pattern I didn’t plan for.
A widened cochlear candidacy. A VA in Missouri got certified to program implants locally. Utah surgeons performed Rwanda’s first pediatric cases. UC Davis did one awake. A woman in BC is five years down a waitlist for hers. Different stories, same direction. More people are getting implanted, in more places, and everyone who makes it through eventually shows up on our table.
Then there’s PRIMA, a retinal implant cleared in Europe, and Biotronik’s LivIQ, investigational and sitting in patients at sixty sites right now. Neither is in your screening binder. One of them has no IFU you can pull.
In the same issue, the FDA declined to reclassify projectile near-misses, so they still don’t get reported. A JMRI review looked at MR safety guidance worldwide and found the same thing underneath all of it: the system leans on the tech in the room paying attention instead of on engineering controls.
That’s the squeeze. Implant volume and variety climbing, the formal safety net holding still.
Gadoquatrane is the one item here that made something easier. Sixty percent less gadolinium, approved down to term neonates. For the MS patient I’ve scanned eleven times, that compounds. It still carries a boxed warning for intrathecal use and NSF, so nothing about your screening changes. Ask your pharmacy what they’re carrying and when.
SAFETY SIGNALS
FDA denies petition to reclassify MRI safety event. By labeling projectile near-misses as user error, the FDA leaves manufacturers off the hook for reporting the exact risks that would protect patients and staff. Radiology Business https://radiologybusiness.com/topics/medical-imaging/magnetic-resonance-imaging-mri/fda-denies-petition-reclassify-mri-safety-event
Medtronic recalls Harmony delivery catheter over tip detachment risk. Class I recall on the delivery catheter only. The Harmony pulmonary valve itself is unaffected, so patients already implanted need nothing, but if your cath lab stocks these lots, check them today. MedTech Dive https://www.medtechdive.com/news/medtronic-recalls-heart-valve-delivery-catheter-for-risk-of-tip-detaching/825186/
Concordance between MR safety guidance documents on conditions for a safe MR environment. Good habits are not a safety program. A global review of MR guidance finds heavy reliance on tech vigilance instead of engineering controls like room layout and MR Conditional equipment. Journal of Magnetic Resonance Imaging https://onlinelibrary.wiley.com/doi/10.1002/jmri.70444?af=R
CONTRAST WATCH
Bayer nets FDA approval for Ambelvist low-dose MRI contrast agent. Gadoquatrane at 0.01 mmol/kg, 60 percent less gadolinium than standard macrocyclics and 20 percent less than gadopiclenol. Approved down to term neonates. Boxed warning for intrathecal administration and NSF still applies. AuntMinnie https://www.auntminnie.com/clinical-news/mri/news/15827675/bayer-healthcare-bayer-nets-fda-approval-for-ambelvist-lowdose-mri-contrast-agent
Bracco launches VUEWAY (gadopiclenol) in Mexico. Commercial launch following COFEPRIS approval in September 2025. Vueway is now cleared in 38 countries with over 4 million doses administered, which makes low-dose the direction of travel rather than a single product story. PR Newswire https://www.prnewswire.com/news-releases/bracco-receives-approval-in-mexico-for-vueway-injection-gadopiclenol-advancing-its-commitment-to-lower-dose-mri-across-global-markets-302830005.html
CLEARED AND COMING
Advanced Bionics gets FDA approval for expanded cochlear implant candidacy in SSD and AHL. The numbers are what matter for screening. Adults qualify at a PTA of 80 dB HL or worse in the poorer ear with under 30 dB HL in the better ear. Utilization among eligible patients sits around 2 percent, so expect volume to move. The Hearing Review https://hearingreview.com/hearing-products/implants-bone-conduction/cochlear-implants/advanced-bionics-receives-fda-approval-for-expanded-cochlear-implant-candidacy-criteria-in-ssd-and-ahl
Retinal implant for blindness debuts in Europe, US launch targeted for 2027. Science Corp’s PRIMA retinal implant cleared in Europe for severe AMD. Start asking now what its MR labeling looks like, because it will reach US screening forms before most departments have a policy for it. STAT https://www.statnews.com/2026/07/22/prima-retinal-implant-for-macular-degeneration-us-timeline/
AI-powered breast ultrasound receives FDA clearance. DeepHealth’s AI breast ultrasound software cleared, folding into RadNet’s automated imaging network and shifting where sonographer time goes. Imaging Technology News http://www.itnonline.com/content/ai-powered-breast-ultrasound-receives-fda-clearance
WORTH READING
UW Health Kids establishes first pediatric interventional radiology suite. A dedicated pediatric IR suite built to roughly double procedural volume and cut wait times, which is the kind of capacity decision that quietly changes a region’s referral patterns. Imaging Technology News http://www.itnonline.com/content/uw-health-kids-establishes-first-pediatric-interventional-radiology-suite
First US patient implanted with Biotronik LivIQ leadless pacemaker. Investigational only, inside the BIO-LivIQ pivotal trial enrolling 325 patients at 60 sites. Far-field atrial sensing for AV synchrony from a single device. Trial devices show up on screening forms with no IFU your department has ever seen, so know the name now. Cardiovascular Business https://cardiovascularbusiness.com/topics/cardiac-imaging/ep-lab/first-us-patient-implanted-biotronik-leadless-pacemaker
Operation Selva brings cochlear implants to Rwanda. University of Utah Health partnered with Rwandan surgeons to perform the country’s first pediatric cochlear implants and build local capacity rather than fly in and leave. University of Utah Health https://healthcare.utah.edu/news/2026/07/operation-selva-brings-cochlear-implants-rwanda
VA medical center to offer cochlear implant programming and services. John J. Pershing VA in Poplar Bluff is now a certified programming center. Veterans previously drove to St. Louis, Memphis, or Little Rock for the eight to twelve visits a first year requires. Access problems are usually logistics problems. US Department of Veterans Affairs https://www.va.gov/poplar-bluff-health-care/news-releases/va-medical-center-to-offer-cochlear-implant-programming-and-services/
BC woman faces five-year wait for cochlear implant, and she is not alone. Providence Health Care’s posted waits run 21 months for candidacy assessment and up to 38 months for surgery after that. The suggested alternative was paying roughly 100,000 dollars out of pocket in the US. CBC News https://www.cbc.ca/news/canada/british-columbia/cochlear-implant-waitlist-b-c-9.7278521
UC Davis Health performs first cochlear implant procedure while patient is awake. Awake implantation under local opens the door for older adults who are poor candidates for general anesthesia, and it changes who gets referred in the first place. UC Davis Health https://health.ucdavis.edu/news/headlines/uc-davis-health-performs-first-cochlear-implant-procedure-while-patient-is-awake/2026/07
THREE THINGS TO DO THIS WEEK
Check whether your cath lab stocks the recalled Harmony delivery catheter lots.
Ask pharmacy when Ambelvist lands and what it replaces.
Add PRIMA and LivIQ to your screening reference before someone walks in with one.
Conditional is written by Tony Oropeza, R.T.(R)(CT)
www.WilhelmAI.com